Regenerative Medicine Applied to Solid Organ Transplantation

Where Do We Stand?

G. Orlando, P. Di Cocco, M. D'Angelo, K. Clemente, A. Famulari, F. Pisani

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The objective of regenerative medicine (RM) and Tissue Engineering (TE) is to create living functional tissues to repair or replace tissues or organ functions. This field holds the promise of regenerating damaged tissues and organs in the body. It has the potential to solve the problems of organ shortage and of toxicities deriving from life-long immunosuppression. In fact, cells in the regenerated organ would match those of the patient, from whom they would normally be derived. In the past decade, RM/TE has achieved striking results which are of interest to the transplant community. However, major roadblocks on the avenue to full success include the need for a deeper understanding of cell biology and of interactions with the extracellular matrix. We are presently not able to grow and expand cells indefinitely and safely in various scenarios where RM/TE may be indicated. The production of adequately vascularized scaffolds to optimize nutrients and oxygen delivery, assessment of the viability and function of the cells in the bioengineered construct, and the costs remain areas of scientific research.

Original languageEnglish
Pages (from-to)1011-1013
Number of pages3
JournalTransplantation Proceedings
Volume42
Issue number4
DOIs
Publication statusPublished - May 2010

Fingerprint

Regenerative Medicine
Organ Transplantation
Tissue Engineering
Cell Communication
Immunosuppression
Extracellular Matrix
Cell Biology
Cell Survival
Oxygen
Transplants
Costs and Cost Analysis
Food
Research

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Regenerative Medicine Applied to Solid Organ Transplantation : Where Do We Stand? / Orlando, G.; Di Cocco, P.; D'Angelo, M.; Clemente, K.; Famulari, A.; Pisani, F.

In: Transplantation Proceedings, Vol. 42, No. 4, 05.2010, p. 1011-1013.

Research output: Contribution to journalArticle

Orlando, G. ; Di Cocco, P. ; D'Angelo, M. ; Clemente, K. ; Famulari, A. ; Pisani, F. / Regenerative Medicine Applied to Solid Organ Transplantation : Where Do We Stand?. In: Transplantation Proceedings. 2010 ; Vol. 42, No. 4. pp. 1011-1013.
@article{40f76fab425c41328078fa0acea680f1,
title = "Regenerative Medicine Applied to Solid Organ Transplantation: Where Do We Stand?",
abstract = "The objective of regenerative medicine (RM) and Tissue Engineering (TE) is to create living functional tissues to repair or replace tissues or organ functions. This field holds the promise of regenerating damaged tissues and organs in the body. It has the potential to solve the problems of organ shortage and of toxicities deriving from life-long immunosuppression. In fact, cells in the regenerated organ would match those of the patient, from whom they would normally be derived. In the past decade, RM/TE has achieved striking results which are of interest to the transplant community. However, major roadblocks on the avenue to full success include the need for a deeper understanding of cell biology and of interactions with the extracellular matrix. We are presently not able to grow and expand cells indefinitely and safely in various scenarios where RM/TE may be indicated. The production of adequately vascularized scaffolds to optimize nutrients and oxygen delivery, assessment of the viability and function of the cells in the bioengineered construct, and the costs remain areas of scientific research.",
author = "G. Orlando and {Di Cocco}, P. and M. D'Angelo and K. Clemente and A. Famulari and F. Pisani",
year = "2010",
month = "5",
doi = "10.1016/j.transproceed.2010.03.066",
language = "English",
volume = "42",
pages = "1011--1013",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Regenerative Medicine Applied to Solid Organ Transplantation

T2 - Where Do We Stand?

AU - Orlando, G.

AU - Di Cocco, P.

AU - D'Angelo, M.

AU - Clemente, K.

AU - Famulari, A.

AU - Pisani, F.

PY - 2010/5

Y1 - 2010/5

N2 - The objective of regenerative medicine (RM) and Tissue Engineering (TE) is to create living functional tissues to repair or replace tissues or organ functions. This field holds the promise of regenerating damaged tissues and organs in the body. It has the potential to solve the problems of organ shortage and of toxicities deriving from life-long immunosuppression. In fact, cells in the regenerated organ would match those of the patient, from whom they would normally be derived. In the past decade, RM/TE has achieved striking results which are of interest to the transplant community. However, major roadblocks on the avenue to full success include the need for a deeper understanding of cell biology and of interactions with the extracellular matrix. We are presently not able to grow and expand cells indefinitely and safely in various scenarios where RM/TE may be indicated. The production of adequately vascularized scaffolds to optimize nutrients and oxygen delivery, assessment of the viability and function of the cells in the bioengineered construct, and the costs remain areas of scientific research.

AB - The objective of regenerative medicine (RM) and Tissue Engineering (TE) is to create living functional tissues to repair or replace tissues or organ functions. This field holds the promise of regenerating damaged tissues and organs in the body. It has the potential to solve the problems of organ shortage and of toxicities deriving from life-long immunosuppression. In fact, cells in the regenerated organ would match those of the patient, from whom they would normally be derived. In the past decade, RM/TE has achieved striking results which are of interest to the transplant community. However, major roadblocks on the avenue to full success include the need for a deeper understanding of cell biology and of interactions with the extracellular matrix. We are presently not able to grow and expand cells indefinitely and safely in various scenarios where RM/TE may be indicated. The production of adequately vascularized scaffolds to optimize nutrients and oxygen delivery, assessment of the viability and function of the cells in the bioengineered construct, and the costs remain areas of scientific research.

UR - http://www.scopus.com/inward/record.url?scp=77952578715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952578715&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2010.03.066

DO - 10.1016/j.transproceed.2010.03.066

M3 - Article

VL - 42

SP - 1011

EP - 1013

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 4

ER -